PLCG2 and colorectal carcinoma: There was a higher percentage of MSI-H patients in the low PLCG2 expression group compared to the high PLCG2 expression group (Figure S9B), and CRC patients with dMMR tended to have lower expression of PLCG2 compared to patients with pMMR (Figure S9C).